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OBJECTIVES The goal of this study was to assess the prognostic power of the pulse pressure-to-stroke index
(PP-to-SVi) ratio for cardiovascular events and mortality in patients with uncomplicated
hypertension.
BACKGROUND The prognostic significance of pulse pressure (PP) has been studied repeatedly, but few data
are available on the PP-to-SVi ratio.
METHODS Invasive hemodynamic measurements, including brachial intra-arterial pressure and stroke
index by the direct oxygen Fick method, were performed in the period 1972 to 1982 in 192
patients with uncomplicated hypertension; their outcome was ascertained in 1994.
RESULTS Age at baseline averaged 37 6 12 years; brachial artery pressure was 165 mm Hg 6 30/89 6
17 mm Hg; PP averaged 76 mm Hg 6 18 mm Hg, and the PP-to-SVi ratio was
1.67 mm Hg/(ml/m2) 6 0.73 mm Hg/(ml/m2). During 3,057 patient years of follow-up,
19 patients died, and 44 experienced at least one fatal or nonfatal cardiovascular event. Cox
regression analysis revealed that the PP-to-SVi ratio was a significant predictor of fatal and
nonfatal cardiovascular events and of all-cause mortality after control for age and gender (p ,
0.01). Its predictive power persisted after additional adjustment for mean arterial pressure and
heart rate. Each 0.75-mm Hg/(ml/m2) increase in the PP-to-SVi ratio was independently
associated with a 79% increase in the risk of a cardiovascular event (p 5 0.01) and a 2.05-fold
greater risk of all-cause mortality (p 5 0.01).
CONCLUSIONS The PP-to-SVi ratio is a significant and independent predictor of cardiovascular events and
mortality in selected patients with uncomplicated hypertension. (J Am Coll Cardiol 2001;38:
227–31) © 2001 by the American College of Cardiology
In the last decade, a number of studies have provided strong
evidence that pulse pressure (PP), measured as the differ-
ence between systolic and diastolic blood pressure (BP) at
the level of the brachial artery, is an independent predictor
of future left ventricular (LV) mass, vascular hypertrophy
and cardiovascular morbidity and mortality (1–15). A high
PP results, at least partly, from stiffening of the arterial tree,
which leads to an increase of systolic BP and a decrease of
diastolic BP at any given level of mean BP. Thus, PP has
been used as a crude index of arterial stiffness, or, conversely,
of arterial compliance in these prognostic studies. However,
arterial stiffness is defined as the relationship between
changes in pressure and volume—and vice versa for arterial
compliance—so that consideration of volume changes could
improve the estimate of the vascular wall properties. Volume
changes of the arterial system are difficult to measure in
man, but stroke volume (SV) has been used as a substitute
for these changes. Therefore, the ratio of SV to PP has been
proposed as an estimate of arterial compliance (16). In spite
of a number of theoretical objections to the use of this ratio
or its reciprocal, Randall et al. (17) and Chemla et al. (18)
have shown that it correlates well with more standard
estimates of arterial compliance. The purpose of the present
study was: 1) to identify the prognostic value of the pulse
pressure-to-stroke index (PP-to-SVi) ratio in patients with
uncomplicated hypertension, and 2) to investigate whether
this ratio would be better than PP alone with regard to the
prediction of mortality and cardiovascular (CV) events. We
applied invasive gold standard techniques for the measure-
ment of brachial artery PP and stroke index (SVi) and used
the PP-to-SVi ratio rather than the inverse because the
development of pressure results from the ejection of blood
in the arterial tree by the LV. The age-dependent difference
between peripheral and central PP was accounted for by
inclusion of age in a multivariable regression analysis.
METHODS
Study population. This analysis includes patients who
were referred to the Hypertension Unit of the University
Hospitals of Leuven between 1972 and 1982 and who
underwent a hemodynamic study for research purposes.
Routine investigations included history, clinical examina-
tion, appropriate laboratory tests, eye-fundus examination,
chest X-ray, electrocardiography at rest, exercise testing,
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pulmonary function tests, intravenous urography and renal
arteriography when indicated. Patients were excluded when
World Health Organization (WHO) stage III organ dam-
age was present at the time of the investigation (19).
Patients with evidence of ischemic heart disease, heart
failure, stroke, claudication, retinal exudates or hemorrhages
or renal insufficiency were excluded. No patient had valvular
heart disease. All patients were in sinus rhythm, and none
had evidence of pulmonary disease or diabetes. Patients had
never been treated for high BP or had their antihypertensive
medication stopped for two weeks or more. The Ethics
Committee of the Faculty of Medicine approved the hemo-
dynamic studies, and participants gave informed consent
after the nature of the procedures had been explained.
Hemodynamic study. All hemodynamic measurements
were performed in the morning in the same laboratory,
where room temperature was 18°C to 22°C, a few days after
hospital admission. The brachial artery was cannulated to
measure systolic and diastolic intra-arterial pressure and to
sample arterial blood; PP was the difference between systolic
and diastolic BP, and mean BP was obtained from electrical
damping. A venous catheter (Swan-Ganz, 93.110.5F) was
introduced in the antecubital vein and positioned in the
pulmonary artery to sample mixed venous blood. Pressures
were registered on a Mingograph 81 recorder (Siemens
Medical, Germany). Cardiac output (l/min) was determined
by the direct oxygen Fick method as described (20) and
normalized for body size as cardiac output divided by body
surface area (cardiac index; [l/min]/m2). Heart rate ([HR]
beats/min) was recorded from the electrocardiogram. Stroke
index (ml/m2) was determined from cardiac index and HR.
The PP-to-SVi ratio (mm Hg/[ml/m2]) was then calculated
as the ratio of PP and SVi. The hemodynamic measure-
ments were obtained with patients in supine rest 30 min
after the technical procedures.
Follow-up. After the baseline examination, the patients
were referred to their usual source of care. Follow-up with
regard to vital status, causes of death and occurrence of
cardiovascular events was performed in 1989 and in 1994, as
described in detail (20,21). Events were coded according to
the Ninth Revision of the International Classification of
Diseases. The following CV events, known to be associated
with hypertension (22), were considered: sudden death,
myocardial infarction, cerebrovascular accident, heart fail-
ure, new-onset angina pectoris, transient ischemic attack
and peripheral vascular disease. Objective evidence was
required for acceptance as described (21). The vital status of
all patients could be determined in 1994 (20). However, two
living patients could not be traced in 1994, so their data
from the 1989 survey (21) were used in this analysis.
Statistical analysis. Database management and statistical
analysis were performed with the SAS software (SAS
Institute Inc., Cary, North Carolina). Data are reported as
mean 6 SD or median and range. The unpaired Student t
test and the chi-square statistic were used for the compar-
ison of groups. Multivariable regression analysis was applied
to identify the determinants of PP and the PP-to-SVi ratio.
The Cox proportional hazards regression model was used
for survival analysis (23,24). Two categories of end points
were considered: 1) all-cause mortality, and 2) fatal and
nonfatal CV events combined. In patients with more than
one CV event, only the first event was considered. The
prognostic value of a variable is given by its relative hazard
rate (RHR). We estimated how much the incidence of the
events would change for approximately one standard devi-
ation increase of PP, SVi and of the PP-to-SVi ratio,
respectively. The principal covariates considered in multi-
variable regression analysis were: age, age squared, gender,
mean BP and HR. Two-sided p values of #0.05 were
considered statistically significant.
RESULTS
Characteristics at baseline. Age of the 192 subjects aver-
aged 37 6 12 years, body mass index 25.9 kg/m2 6
3.6 kg/m2 and body surface area 1.85 m2 6 1.18 m2; 68%
were men. Conventional BP on admission to the hospital
was 180 mm Hg 6 31/111 6 20 mm Hg. Of the patients,
29% had never received antihypertensive drugs, and treat-
ment was interrupted at least two weeks before the baseline
investigations in the others. The majority of the patients
had essential hypertension (n 5 165); 10 had a renal artery
stenosis, which was considered significant in three, and 17
had evidence of renal parenchymal disease but without renal
insufficiency. Serum creatinine averaged 93.8 mmol/l 6
17.7 mmol/l. Serum cholesterol averaged 5.59 mmol/l 6
1.11 mmol/l, and the sum of the electrocardiographic
voltages SV1 1 RV5 averaged 3.08 mV 6 1.04 mV; 39%
were current smokers. Heart rate and intra-arterial BP
averaged 80 beats/min 6 14 beats/min and 165 mm Hg 6
30/89 6 17 mm Hg, respectively, at the hemodynamic
investigation. Pulse pressure was 76 mm Hg 6 18 mm Hg,
SVi 49.7 ml/m2 6 13.8 ml/m2 and the PP-to-SVi ratio
1.67 mm Hg/(ml/m2) 6 0.73 mm Hg/(ml/m2). Table 1
shows that age, age squared, gender and mean BP explained
51% of the variance of PP, whereas 60% of the variance of
the PP-to-SVi ratio was explained by age, age squared, HR
and mean BP; there was no significant effect of etiology of
hypertension.
Abbreviations and Acronyms
BP 5 blood pressure
CV 5 cardiovascular
HR 5 heart rate
PP 5 pulse pressure
PP-to-SVi ratio 5 pulse pressure-to-stroke index ratio
RHR 5 relative hazard rate
SV 5 stroke volume
SVi 5 stroke index
SVi-to-PP ratio 5 stroke index-to-pulse pressure ratio
WHO 5 World Health Organization
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Follow-up. Total follow-up time, that is, time until death
or until the last available information, amounted to 3,057
patient years, with a median follow-up of 16.5 (range 0.7 to
21.1) years. Fifteen men and four women died at an average
age of 53.3 (range 32.5 to 78.1) years or 6.9 (range 0.7 to
20.1) years after the baseline examination. Thirty-two men
and 12 women suffered at least one fatal or nonfatal CV
event, the first event occurring at the age of 56.6 (range 32.5
to 78.1) years or a median of 8.3 (range 0.7 to 2.2) years
after the baseline studies. Table 2 summarizes the causes of
death and the first occurring CV events.
Baseline characteristics of patients with and patients
without events during follow-up. Table 3 shows that,
compared with survivors without a CV event, patients who
suffered a CV event or died were older and had lower SVi
and higher BP, PP and a higher PP-to-SVi ratio.
Prognostic value of PP and of the PP-to-SVi ratio. Both
age and its quadratic term were required to describe the
relation of CV events with age, but age squared was not
significant for all-cause mortality. Etiology of hypertension
was not a significant predictor of outcome. As shown in
Table 4, PP significantly predicted CV events (p 5 0.03)
and death (p 5 0.02) after control for age and gender, but
its prognostic power did not persist after additional adjust-
ment for mean BP (p $ 0.13). By contrast, the PP-to-SVi
ratio was a strong predictor of both CV events (p 5 0.007)
and mortality (p , 0.001), which remained significant after
adjustment for mean BP and HR; the adjusted RHR
associated with a 0.75 mm Hg/(ml/m2) higher PP-to-SVi
ratio was 1.79 (p 5 0.01) for CV events and 2.05 (p 5 0.01)
for all-cause mortality. Adding electrocardiographic volt-
ages to these models did not affect the results.
When the PP-to-SVi ratio, age, age squared, gender,
mean BP and HR were offered to the models, multivariable
regression analysis retained the PP-to-SVi ratio (p 5
0.007), gender (p , 0.001), age (p 5 0.01) and age squared
(p 5 0.03) as significant predictors of CV events and the
PP-to-SVi ratio (p , 0.001), gender (p 5 0.001) and age
(p 5 0.08) for the prediction of all-cause mortality.
Stroke index alone did not predict the incidence of CV
events after control for age and gender (p 5 0.40). The
RHR was, however, significant for mortality (p 5 0.02) and
amounted to 0.42 (95% confidence interval: 0.20 to 0.87)
per 15 ml/m2 increase of SVi; the RHR was 0.49 (p 5 0.07)
after additional adjustment for mean BP. When PP and SVi
were offered separately to the models, together with age, age
squared, gender, mean BP and HR, PP (RHR: 1.50; p 5
0.03), but not SVi, predicted the incidence of CV events in
addition to age, age squared and gender. By contrast, both
PP (RHR: 1.80; p 5 0.04) and SVi (RHR: 0.47; p 5 0.04)
predicted death in addition to age and gender.
DISCUSSION
The main finding of this study is that the PP-to-SVi ratio
is a significant and independent predictor of CV events and
all-cause mortality in hypertensive patients with limited
target organ damage (WHO stage #II) and no associated
cardiovascular diseases or other clinical conditions (19,25) at
baseline. The results, furthermore, suggest that the PP-to-
SVi ratio may be a more robust predictor of outcome than
PP alone in this study population.
Prognostic value of PP and of the PP-to-SVi ratio. The
prognostic value of PP has been examined in the population
(1,4,8,9,12,14), in hypertensive patients (2,3,5,7,10,13,15),
in survivors of myocardial infarction (6) and in patients with
LV dysfunction (11). Pulse pressure was found to be
predictive for future LV mass and vascular hypertrophy (5)
and of cardiovascular morbidity and mortality (1–4,6–15).
Overall, its prognostic value remained significant after
adjustment for variable sets of risk factors, which usually
included systolic, diastolic or mean BP. Pulse pressure was
derived from conventional upper arm BP measurements in
most studies. Two studies applied ambulatory BP monitor-
ing (5,7), and the results suggested that the prognostic value
of PP can only be partially attributed to the alerting reaction
evoked by the clinic visit. Recently, de Simone et al. (26)
assessed SVi noninvasively by use of echocardiography and
derived PP from conventionally measured BP in 294 men
and women with arterial hypertension. Through a mean
10-year follow-up period, 50 subjects experienced at least
one CV complication, and 14 subjects died. The stroke
index-to-pulse pressure ratio (SVi-to-PP) significantly pre-
Table 2. Causes of Death and of Fatal and Nonfatal
Cardiovascular Events During Follow-up
First Cardiovascular
Event (n 5 44)
Fatal Events
(n 5 19)
Fatal
(n 5 10)
Nonfatal
(n 5 34)
Cardiovascular events:
Sudden death 3 — 5
Myocardial infarction 2 3 3
Cerebral stroke 4 5 6
Heart failure 1 3 1
Angina pectoris — 14 —
Transient ischemic attack — 1 —
Peripheral arterial disease — 8 —
Noncardiovascular death — — 4
Table 1. Determinants of Pulse Pressure and the
PP-to-SVi Ratio
Pulse Pressure
(mm Hg)
PP-to-SVi Ratio
(mm Hg/[ml/m2])
Intercept 160.8† 20.514†
Age (yr) 22.33† 20.0697†
Age squared (yr2) 10.0326† 10.00117†
Gender (m 5 1; w 5 0) 24.64* NS
Heart rate (beats/min) NS 10.0120†
Mean brachial artery
pressure (mm Hg)
10.509† 10.0172†
R2 0.51† 0.60†
*p # 0.05; †p # 0.001; NS p . 0.05. Values are regression coefficients from
multivariable regression analysis.
m 5 men; PP-to-SVi ratio 5 pulse pressure-to-stroke index ratio; w 5 women.
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dicted the incidence of all CV events but not of fatal events.
In this study we assessed the PP-to-SVi ratio by invasive
techniques, that is, intra-arterial measurement of BP and
determination of SVi by the direct oxygen Fick method,
which is considered the gold standard for hemodynamic
evaluations. We found that the invasive PP-to-SVi ratio
was a significant predictor of CV events and of all-cause
mortality, which was independent of age, gender, mean BP
and HR. Moreover, the PP-to-SVi ratio appeared to be a
more robust predictor than PP alone, which lost its predic-
tive power when mean BP was included in the model. This
could result from the fact that the PP-to-SVi ratio better
reflects vascular wall properties because it accounts for the
dependence of PP on SVi. Stiffening of the arterial tree is
due to loss of elasticity of the vascular wall and to athero-
sclerosis, which is likely to precede the occurrence of clinical
CV events and death. On the other hand, the independent
prognostic power of a low SVi, at least for mortality, may
have contributed to the prognostic power of the PP-to-SVi
ratio. Although none of our patients had a history, signs or
symptoms of heart failure, a low SVi may reflect impaired
LV function.
Study limitations. A number of theoretical objections have
been raised against the use of the SVi-to-PP ratio, or its
reciprocal, as a measure of arterial compliance or stiffness
(17,27). First, only part of the SV contributes to the increase
in arterial volume within the time that peak pressure is
reached. This portion of SV is, in fact, not known, but it is
assumed that SV is closely related to the relevant change in
volume. Second, SV depends on LV function and a number
of other factors, but it can be argued that this objection is of
lesser importance because PP results from the actual in-
crease in volume at the time of the peak pressure. In spite of
these objections, it has been shown that the SVi-to-PP ratio
is strongly related to more standard assessments of arterial
compliance in studies in animals (17) and in man (18). As
in all studies on the prognostic power of PP in man, we have
calculated PP as the difference between systolic and diastolic
BP measured at the level of the brachial artery, whereas
aortic pressure would have been more appropriate. Periph-
eral PP is indeed higher than PP derived from central
measurements, and the difference decreases with advancing
age. It is likely that the inclusion of age in the multivariable
models accounted, at least partly, for this effect. Whereas
the prognostic value of the PP-to-SVi ratio appeared to be
more robust than that of PP alone, the lack of an indepen-
dent effect of PP after adjustment for mean BP may be due
to the smaller number of subjects in this invasive hemody-
namic study than in other studies. On the other hand, our
study population was younger than in those most previous
reports, and the results are, in fact, compatible with those of
Sesso et al. (28) who recently reported that PP lost its
prognostic significance for CV disease in men aged #60
Table 3. Baseline Characteristics of Patients With and Patients Without Events
During Follow-up
No Events* Cardiovascular Events Fatal Events
Number 146 44 19
Men (%) 66.4 72.7 78.9
Age (yr) 35.4 6 12.1 43.1 6 9.6‡ 44.9 6 11.5‡
Body mass index (kg/m2) 25.7 6 3.6 26.5 6 3.8 27.0 6 3.7
Heart rate (beats/min) 80.7 6 13.9 78.7 6 13.7 84.7 6 12.8
Brachial artery pressure (mm Hg)
Systolic 162 6 30 175 6 28‡ 179 6 29†
Diastolic 87.6 6 17.5 94.4 6 15.4† 94.1 6 14.8
Mean 115 6 22 125 6 19‡ 128 6 20†
PP (mm Hg) 74.1 6 17.7 81.0 6 19.2† 85.2 6 22.1‡
Stroke index (ml/m2) 50.7 6 13.4 46.2 6 14.8† 41.2 6 11.6‡
PP-to-SVi ratio (mm Hg/[ml/m2]) 1.58 6 0.63 1.97 6 0.93‡ 2.31 6 1.13‡
Smoking (%) 34.2 52.3† 47.4
Serum cholesterol (mg/dl) 215 6 44 222 6 41 211 6 30
SV1 1 RV5 (mV) 3.03 6 1.05 3.31 6 0.97 3.25 6 1.06
*Survivors without cardiovascular event; †p # 0.05; ‡p # 0.01; comparison with event-free patients. Values are means 6 SD or
% of patients.
PP 5 pulse pressure; PP-to-SVi 5 pulse pressure-to-stroke index.
Table 4. Relative Hazard Rate of PP and of the PP-to-SVi
Ratio for Cardiovascular Events and All-cause Mortality After
Cumulative Adjustment for: A) Age and Gender, B) Mean
Brachial Artery Pressure, and C) Heart Rate
Adjusted
For Cardiovascular Events
All-cause
Mortality
Pulse Pressure (RHR per 20 mm Hg)
A) 1.50 (1.04–2.15)* 1.96 (1.13–3.39)*
B) 1.44 (0.90–2.30) 1.68 (0.85–3.33)
C) 1.46 (0.91–2.35) 1.65 (0.83–3.30)
PP-to-SVi Ratio (RHR per 0.75 mm Hg/[(ml/m2)]
A) 1.60 (1.14–2.24)† 2.30 (1.47–3.58)‡
B) 1.57 (1.04–2.35)* 2.25 (1.31–3.85)†
C) 1.79 (1.15–2.80)† 2.05 (1.15–3.65)†
*p # 0.05; †p # 0.01; ‡p # 0.001. Values are RHR and 95% confidence limits for
approximately one standard deviation increase of the independent variable of interest.
A) 5 age and gender (1 age squared for cardiovascular events); B) variables from
A) 1 mean brachial artery pressure; C) variables from A) and B) 1 heart rate; PP 5
pulse pressure; PP-to-SVi 5 pulse pressure-to-stroke index; RHR 5 relative hazard
rate.
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years when mean BP was included in the model. Finally, the
use of invasive hemodynamic measurements is undoubtedly
a limitation with regard to its applicability in the assessment
of the hypertensive patient. On the other hand, the use of
intra-arterial BP measurements and of the direct oxygen
Fick method for the determination of SVi can be regarded
as a strength of the study because of their greater accuracy
and validity. The predictive power of the invasive PP-to-
SVi ratio may be stronger than that of the ratio obtained by
noninvasive means. In view of these limitations, a more
direct and clinically applicable assessment of vascular stiff-
ness would be needed to answer the question whether the
predictive power of PP and the PP-to-SVi ratio is truly a
reflection of increased vascular stiffness.
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